Metronomic Capecitabine in Stage III Gastric Cancer
NCT06313567
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
722
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Metronomic capecitabine group
OTHER:
Observation
Sponsor
Fudan University